baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Context Therapeutics/ US21077P1084 /

2024-11-12 8:46:29 PM	Chg. +0.04	Volume	Bid8:53:37 PM	Ask8:53:37 PM	High	Low
2.09USD	+1.95%	10,427 Turnover: 20,882.52	2.08Bid Size: 100	2.10Ask Size: 300	2.10	1.94

GlobeNewswire 08-07 Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results

GlobeNewswire 08-01 Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations

GlobeNewswire 07-10 Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

GlobeNewswire 05-08 Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

GlobeNewswire 05-02 Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM...

GlobeNewswire 05-02 Context Therapeutics Announces $100 Million Private Placement

GlobeNewswire 04-01 Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers

GlobeNewswire 03-21 Context Therapeutics Reports Full Year 2023 Operating and Financial Results

GlobeNewswire 2023-11-09 Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

GlobeNewswire 2023-10-31 Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of i...

GlobeNewswire 2023-09-27 Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunothera...

Newsfile Corp 2022-10-20 Context Therapeutics to Participate in the ThinkEquity Conference

GlobeNewswire 2022-03-23 Context Therapeutics® Reports Full Year 2021 Operating and Financial Results

GlobeNewswire 2022-03-09 Proactive news headlines including Bitcoin, Lifeist Wellness, Imperial Helium, Fabled Copper, Contex...

GlobeNewswire 2022-03-09 Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Associa...

GlobeNewswire 2022-02-24 Proactive news headlines including Thunderbird Entertainment, NorthWest Copper, East Side Games, Ame...

GlobeNewswire 2022-02-23 Proactive news headlines including TRACON Pharmaceuticals, Gratomic, Benchmark Metals, Potent Ventur...

GlobeNewswire 2022-02-22 Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO Forum

GlobeNewswire 2022-01-05 Context Therapeutics® Strengthens Research & Development Team

GlobeNewswire 2022-01-04 Context Therapeutics® to Participate in Two January 2022 Investor Conferences

GlobeNewswire 2021-12-10 Proactive news headlines including Tesla, Great Atlantic Resources, American Battery Technology Comp...

GlobeNewswire 2021-12-10 Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio...

GlobeNewswire 2021-12-07 Proactive news headlines including BuzzFeed, Steppe Gold, Esports Entertainment Group, Sanatana Res...

GlobeNewswire 2021-12-06 Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement

GlobeNewswire 2021-12-03 Proactive news headlines including Elon Musk, Vuzix, Context Therapeutics and American Manganese

Context Therapeutics/ US21077P1084 /

If you wish to receive reply to your feedback, please provide your email address.